1246 related articles for article (PubMed ID: 1422788)
1. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease.
Heyes MP; Saito K; Crowley JS; Davis LE; Demitrack MA; Der M; Dilling LA; Elia J; Kruesi MJ; Lackner A
Brain; 1992 Oct; 115 ( Pt 5)():1249-73. PubMed ID: 1422788
[TBL] [Abstract][Full Text] [Related]
2. A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate.
Heyes MP; Saito K; Major EO; Milstien S; Markey SP; Vickers JH
Brain; 1993 Dec; 116 ( Pt 6)():1425-50. PubMed ID: 8293279
[TBL] [Abstract][Full Text] [Related]
3. Inter-relationships between quinolinic acid, neuroactive kynurenines, neopterin and beta 2-microglobulin in cerebrospinal fluid and serum of HIV-1-infected patients.
Heyes MP; Brew BJ; Saito K; Quearry BJ; Price RW; Lee K; Bhalla RB; Der M; Markey SP
J Neuroimmunol; 1992 Sep; 40(1):71-80. PubMed ID: 1387655
[TBL] [Abstract][Full Text] [Related]
4. Relationship of neurologic status in macaques infected with the simian immunodeficiency virus to cerebrospinal fluid quinolinic acid and kynurenic acid.
Heyes MP; Jordan EK; Lee K; Saito K; Frank JA; Snoy PJ; Markey SP; Gravell M
Brain Res; 1992 Jan; 570(1-2):237-50. PubMed ID: 1535532
[TBL] [Abstract][Full Text] [Related]
5. Sustained increases in cerebrospinal fluid quinolinic acid concentrations in rhesus macaques (Macaca mulatta) naturally infected with simian retrovirus type-D.
Heyes MP; Gravell M; London WT; Eckhaus M; Vickers JH; Yergey JA; April M; Blackmore D; Markey SP
Brain Res; 1990 Oct; 531(1-2):148-58. PubMed ID: 1963097
[TBL] [Abstract][Full Text] [Related]
6. Increased ratio of quinolinic acid to kynurenic acid in cerebrospinal fluid of D retrovirus-infected rhesus macaques: relationship to clinical and viral status.
Heyes MP; Mefford IN; Quearry BJ; Dedhia M; Lackner A
Ann Neurol; 1990 Jun; 27(6):666-75. PubMed ID: 2163238
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of delayed increases in kynurenine pathway metabolism in damaged brain regions following transient cerebral ischemia.
Saito K; Nowak TS; Markey SP; Heyes MP
J Neurochem; 1993 Jan; 60(1):180-92. PubMed ID: 8417138
[TBL] [Abstract][Full Text] [Related]
8. Kynurenine pathway metabolites in cerebrospinal fluid and serum in complex partial seizures.
Heyes MP; Saito K; Devinsky O; Nadi NS
Epilepsia; 1994; 35(2):251-7. PubMed ID: 8156942
[TBL] [Abstract][Full Text] [Related]
9. Sources of the neurotoxin quinolinic acid in the brain of HIV-1-infected patients and retrovirus-infected macaques.
Heyes MP; Saito K; Lackner A; Wiley CA; Achim CL; Markey SP
FASEB J; 1998 Jul; 12(10):881-96. PubMed ID: 9657528
[TBL] [Abstract][Full Text] [Related]
10. Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse.
Saito K; Markey SP; Heyes MP
Neuroscience; 1992 Nov; 51(1):25-39. PubMed ID: 1465184
[TBL] [Abstract][Full Text] [Related]
11. Central kynurenine pathway shift with age in women.
de Bie J; Guest J; Guillemin GJ; Grant R
J Neurochem; 2016 Mar; 136(5):995-1003. PubMed ID: 26670548
[TBL] [Abstract][Full Text] [Related]
12. Increased cerebrospinal fluid quinolinic acid, kynurenic acid, and L-kynurenine in acute septicemia.
Heyes MP; Lackner A
J Neurochem; 1990 Jul; 55(1):338-41. PubMed ID: 2141357
[TBL] [Abstract][Full Text] [Related]
13. A role for inflammatory metabolites as modulators of the glutamate N-methyl-D-aspartate receptor in depression and suicidality.
Bay-Richter C; Linderholm KR; Lim CK; Samuelsson M; Träskman-Bendz L; Guillemin GJ; Erhardt S; Brundin L
Brain Behav Immun; 2015 Jan; 43():110-7. PubMed ID: 25124710
[TBL] [Abstract][Full Text] [Related]
14. A mechanism for increased quinolinic acid formation following acute systemic immune stimulation.
Saito K; Crowley JS; Markey SP; Heyes MP
J Biol Chem; 1993 Jul; 268(21):15496-503. PubMed ID: 8340378
[TBL] [Abstract][Full Text] [Related]
15. Activation of the kynurenine pathway and increased production of the excitotoxin quinolinic acid following traumatic brain injury in humans.
Yan EB; Frugier T; Lim CK; Heng B; Sundaram G; Tan M; Rosenfeld JV; Walker DW; Guillemin GJ; Morganti-Kossmann MC
J Neuroinflammation; 2015 May; 12():110. PubMed ID: 26025142
[TBL] [Abstract][Full Text] [Related]
16. Kynurenine pathway enzymes in brain: responses to ischemic brain injury versus systemic immune activation.
Saito K; Nowak TS; Suyama K; Quearry BJ; Saito M; Crowley JS; Markey SP; Heyes MP
J Neurochem; 1993 Dec; 61(6):2061-70. PubMed ID: 8245962
[TBL] [Abstract][Full Text] [Related]
17. Dynamic changes in kynurenine pathway metabolites in multiple sclerosis: A systematic review.
Fathi M; Vakili K; Yaghoobpoor S; Tavasol A; Jazi K; Mohamadkhani A; Klegeris A; McElhinney A; Mafi Z; Hajiesmaeili M; Sayehmiri F
Front Immunol; 2022; 13():1013784. PubMed ID: 36426364
[TBL] [Abstract][Full Text] [Related]
18. [Biochemical studies on AIDS dementia complex--possible contribution of quinolinic acid during brain damage].
Saito K
Rinsho Byori; 1995 Sep; 43(9):891-901. PubMed ID: 7474452
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of increases in L-kynurenine and quinolinic acid in renal insufficiency.
Saito K; Fujigaki S; Heyes MP; Shibata K; Takemura M; Fujii H; Wada H; Noma A; Seishima M
Am J Physiol Renal Physiol; 2000 Sep; 279(3):F565-72. PubMed ID: 10966936
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid levels of kynurenine pathway metabolites in patients with eating disorders: relation to clinical and biochemical variable.
Demitrack MA; Heyes MP; Altemus M; Pigott TA; Gold PW
Biol Psychiatry; 1995 Apr; 37(8):512-20. PubMed ID: 7542489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]